Nature Medicine and the Volkswagen Foundation present:
Herrenhausen Symposium on Stem Cells and Regenerative Medicine
|
What are the most important problems to overcome to make progress in the fields of stem cells and regenerative medicine? Nature Medicine,
in consultation with the research community, has identified a series of
roadblocks to translational research on stem cells and regenerative
medicine. A subset of leaders in the field will attend the Herrenhausen
Symposium and participate in an interdisciplinary discussion that will
point in the direction of solutions to the greatest challenges that the
fields of stem cells and regenerative medicine face.
The symposium
will be a closed event. In addition to the invited speakers, 10-15
attendees will be chosen to participate on the basis of their
application for admission. Preference will be given to young and
early-career investigators (assistant professors, lecturers, research
associates, postdoctoral researchers and clinical fellows) who are
currently working in related areas. |
October 8-10, 2013 Hanover, Germany |
|
SPEAKERS: Salvador Aznar-Benitah Christopher Baum Paolo Bianco Oliver Brüstle Kenneth Chien Stefanie Dimmeler Sheng Ding Paul Frenette Wolfram Goessling Magdalena Götz Axel Haverich Sally Lowell Ulrich Martin Alysson Muotri Alexander Meissner | Charles Murry Trista North Maria Pia Cosma Shahin Rafii Thomas Rando Pamela Robey Michael Rudnicki Manuel Serrano Frank Staal Masayo Takahashi Alan Trounson Amy Wagers Paul Whiting Zhong Zhong |
|
ORGANIZERS: Kevin Da Silva (Nature Medicine, USA) Oliver Grewe (Volkswagen Foundation, Germany) Juan Carlos Lopez (Nature Medicine, USA) Carolina Pola (Nature Medicine, USA) Attendance is by application only.
Attendees will be chosen to participate on the basis of their
application for admission. Application Deadline: July 10, 2013 Image credit: Mouse prostate sphere
Maher Hanoun from Paul Frenette's lab (Albert Einstein College of
Medicine, USA) |
|
|
As a registered user of Nature Publishing Group's Web sites, our database indicates that you have opted-in to receive product |
|
|
No comments:
Post a Comment